Question 1

What are the negative side effects of hCG?

Accepted Answer

The one harm the published record documents in any detail is ovarian hyperstimulation syndrome, usually shortened to OHSS. It happens when the ovaries over-respond to fertility stimulation, and the trigger injection is the step most closely tied to it. A 2004 review states plainly that the development of OHSS almost always follows hCG administration. The same review names severe OHSS as one of the major complications of the controlled stimulation used to prepare eggs for IVF. Beyond that the list thins out quickly, since the other effects tied to hCG in these sources were seen where the body makes its own hormone in pregnancy, or in boys given it for undescended testicles, and each has its own section below. That is a short list, and its shortness describes where hCG has been studied rather than how little goes wrong with it.

Question 2

How often does an hCG trigger cause ovarian hyperstimulation?

Accepted Answer

Two sources put numbers on it, and they are worth reading together. In a retrospective cohort of high-responding women, the first group of 74 received a GnRH agonist trigger with the concomitant use of 1500 IU of urinary hCG immediately after oocyte retrieval. In that group, late-onset OHSS was observed in two patients, one severe case and one moderate case. In the comparison group, which froze every embryo instead, none of the patients experienced moderate or severe OHSS. The second source is larger and randomised. A 2025 network meta-analysis reported hyperstimulation rates significantly lower with the GnRH agonist trigger than with hCG, at a risk ratio of 0.56 with a confidence interval of 0.19 to 1.75. That interval runs past 1, the point of no difference, so the direction points one way while the size of the gap is not pinned down by these trials.

Question 3

Does pairing hCG with a second trigger change the risk?

Accepted Answer

The 2025 analysis compared hCG trigger with GnRH agonist trigger, dual trigger, and double trigger across twelve trials comprising 1,931 women. Dual and double are the authors' names for approaches that use more than one triggering hormone in the same cycle. For those two combinations, the authors report there were no RCTs reporting ovarian hyperstimulation syndrome rates at all. The combined approaches were tested for pregnancy, and the hyperstimulation question was simply not answered for them in any trial the authors could pool. The authors did find no significant differences in the number of eggs retrieved, mature eggs or miscarriage rates across the four approaches. So on miscarriage the four looked alike, while on hyperstimulation the combinations remain an open question rather than a cleared one.

Question 4

What does hCG do to a man's body, on the safety record?

Accepted Answer

The male work behind this page is a stimulation test in thirty men with chronic spinal cord injury, aged 18 to 65 and injured for more than a year. Blood was drawn before each of two injections, and the men returned on day 3 for a final blood sample collection. The abstract reports testosterone and nothing about how the men felt, whether the injection sites reacted, or whether anything went wrong. A study built to read a hormone across three mornings is not built to catch a side effect, and an abstract that never mentions harm has not ruled it out. The authors' own conclusion was about the test, finding no additional benefit from lower than conventional doses of hCG.

Question 5

Can hCG cause breast growth in men?

Accepted Answer

A 2008 review of breast enlargement in adolescent boys says recent literature has begun to illuminate other potential mechanisms beyond the old balance between estrogen and androgen. Among those mechanisms, the review lists receptors for human chorionic gonadotropin and luteinizing hormone on male breast tissue as possibly playing a role. A receptor is a docking point a hormone can act through, so the observation is that male breast tissue has somewhere for hCG to land, which is a long way from a study showing injected hCG enlarged anyone's chest. No study among the research behind this page gave men hCG and then examined breast tissue. The link therefore stays a proposed mechanism rather than a counted harm, and that does not mean the worry is unfounded.

Question 6

What side effects came up when boys were given hCG?

Accepted Answer

Undescended testicles are the one setting in these sources where hCG was given to males as a course rather than a test. A 1979 review shows what clinicians were weighing. It describes an alternative given by nasal spray, the releasing hormone of luteotropic hormone, as a possible alternative approach for the condition. If that spray matched hCG's success rate, the authors wrote, it may combine the advantage of painlessness with no androgenic side effects. Read that sentence backwards and it describes the hCG course. Androgenic means driven by male hormones, and the selling points were an end to injection pain and the absence of those effects. The abstract treats both as part of giving hCG, though it never counts how often either occurred. A 1995 review adds that both tubular and interstitial damage already can be found in these testes in the first months of life. Damage found in a treated testis can belong to the condition rather than to the hormone given for it.

Question 7

Can an hCG injection push the thyroid into overdrive?

Accepted Answer

The thyroid link is real, and it was documented in pregnancy rather than after an injection. A 2013 review puts gestational hyperthyroidism at approximately one to two cases per 1000 pregnancies. Graves' disease, which is autoimmune in nature, is the usual cause, the review notes, and the form driven by hCG is a smaller share of that figure. The review stresses why it matters to catch, because adverse outcomes can occur in both the mother and the offspring. Pregnancy pushes hCG to levels the body sustains for weeks, and the thyroid effect was observed there. No study among the research behind this page measured thyroid function in anyone after an hCG injection. Why the hormone touches the thyroid at all is covered on the the HCG overview overview.

Question 8

Why do bodybuilders take hCG, and what is documented about that use?

Accepted Answer

The research behind this page does not study that use, so what it holds is the clinical frame the use borrows from. A 2020 review of low testosterone in men notes that intensive exercise training might be a cause of functional hypogonadism. Hypogonadism means the body making too little testosterone, and functional means a state of the body rather than a damaged organ. The same review sorts the condition by where the fault sits, either in the testes or in a hypothalamic-pituitary dysfunction higher up. That sorting is why a stimulation test exists, because hCG asks the testes directly whether they can answer. None of it describes hCG given beside anabolic steroids, on a gym schedule, for months. For that pattern of use the safety record is not thin. It is absent, and the two-day test in spinal cord injury remains the closest male exposure on file.

Question 9

What is known about repeated hCG injections?

Accepted Answer

Repeated use in the published record belongs to women in IVF, not to men. hCG has been given as luteal support, meaning hormone given after egg collection to hold up the womb lining while an embryo implants. A 2008 review of that practice states that the date of initiation and discontinuation of supplemented hormones is not adequately studied in the literature. It describes luteal support as an essential requirement for optimal success rates in stimulated IVF cycles. Even where hCG is repeated on purpose, when to start and when to stop were open questions for the field. For men the published exposure is two injections on consecutive days. How often a man injects is therefore a question this record cannot answer on safety, because nobody in it was followed through a schedule of any length. A two-day test and a standing routine are different exposures, and only the first has been measured.

Question 10

What does hCG interact with?

Accepted Answer

No study among the research behind this page tested hCG against a list of medicines for interactions. The pairings on record are deliberate ones inside fertility protocols, covered in the trigger sections above, where the combined approaches were never assessed for hyperstimulation. The nearest thing to an interaction study runs in the other direction, from the environment onto the body's own hCG. In 2,039 pregnant women in Sweden, higher exposure to bisphenol A was associated with lower hCG. The authors concluded that higher exposure to several endocrine disrupting chemicals during pregnancy was associated with a lower hCG, despite small effect sizes. That is a finding about the placenta making less of its own hormone, and it does not tell anyone what a chemical does to an injected dose. Whether hCG can be combined with growth hormone is a comparison question, and the HCG comparison page works through it.

Question 11

Is the hCG diet a safety question?

Accepted Answer

In the research behind this page it appears only as a toxicology question, and that framing is itself the finding. A 2012 toxicology review says the dieting agents it covered were reviewed because of their rising use and availability through internet sales. Human chorionic gonadotropin hormone sits on that list beside ephedra, clenbuterol, fenfluramine, sibutramine and thyroid hormone. The authors close on the point that the internet makes even banned products readily accessible. Keep three things apart when reading this. A prescription written for a fertility or hormone diagnosis is one use. A clinician giving hCG outside that diagnosis is a second. A diet regimen sold to the public is a third, and this abstract does not say which harms it pins on hCG in particular. It records that the hormone was among agents reviewed for toxicity, which is a flag rather than a measured rate of harm.

Question 12

Has the FDA recalled hCG?

Accepted Answer

Ten times, in the enforcement file behind this page, and every record concerns compounded hCG. They were filed between 2014 and 2020 against six compounding pharmacies in Texas, Florida and Wisconsin. One entry, for 3000 IU vials, cites inadequate processes and equipment to assure the sterility of products intended to be sterile. Another, for a 6000 IU lyophilized vial, records a lack of assurance of sterility. The strengths on file run from a 125 IU syringe for subcutaneous use up to vials of 12,000 IU. The 125 IU syringe is the one with mold confirmed in it, and it is the entry the agency classed most seriously. A sterility recall is about the conditions a vial was filled under, which no one holding it can see. How to search these records for a given strength or pharmacy is set out on the HCG sourcing page.

Question 13

Does any of this apply to hCG bought outside a pharmacy?

Accepted Answer

Every number above was produced with pharmacy material given under a protocol, and the recall file shows that even licensed compounding has failed on sterility, solvent and potency. The documented presentations are prescription products, one of them a Human Chorionic Gonadotropin 6,000 iu/Vial, For SC Use, Lyophilized, Rx Only. One compounded entry describes its 1,250 IU vial as made up with mannitol and sodium phosphate, lyophilized and unpreserved. Unpreserved means nothing was added to stop microbes growing once the vial is opened. A vial bought outside a pharmacy has no label a regulator checked, so none of those details can be taken as given. No analysis among the research behind this page measured the identity, strength or sterility of hCG sold that way. Its risks are unmeasured, and an unmeasured risk is not a low one.

Question 14

Who was left out of the hCG studies?

Accepted Answer

The randomised trigger trials were pooled for predicted healthy responders undergoing ovarian stimulation and in vitro fertilization. The 74-woman cohort was the opposite slice, high responder women given a GnRH antagonist protocol between April 2011 and March 2015. The male test drew men with spinal cord injury and able-bodied men between 18 and 65. That leaves out men over 65, teenage boys outside the undescended-testicle work, anyone using hCG beside anabolic steroids or growth hormone, and anyone dieting. It also leaves out time. None of the studies covered here followed a person through months of repeated injections, which is the use most people asking this question have in mind. Being left out is not evidence of danger to those groups, and it means the record never asked about them.

Question 15

Does hCG cause cancer?

Accepted Answer

The record ties hCG to tumours in the opposite direction from the worry, because some tumours make it. In a study across 11 children's hospitals, tumour markers were assessed in 309 out of 519 young patients with ovarian masses. β-HCG was present among all the best-performing marker combinations for flagging malignancy in that group. A 1990 review of molar pregnancy says measuring hCG variants is of value not only in monitoring response to therapy, but also as prognostic indicators. A tumour that makes a hormone is not the same as a hormone that makes tumours. One 1999 review even lists elevated hCG among hormone changes in preeclampsia that may act together to decrease breast cancer risk. That is an association in pregnancy at the body's own levels. No study among the research behind this page followed cancer rates in people given hCG, so neither direction has been measured for an injection.

Question 16

Why is the hCG harm record this thin?

Accepted Answer

Because most of the published work on hCG measures it rather than gives it. It is the pregnancy test, the tumour marker, the number watched after an ectopic pregnancy and the reading taken in birth cohorts. One birth-cohort study of 541 participants looked at hCG as a hormone required for male development that may be a target of phthalate exposure. When a hormone is mostly measured, its harm record ends up describing the conditions it marks. The work where hCG is given was built to count pregnancies, to read testosterone over three days, or to bring a testis down in a small boy. Each of those designs counted one outcome and stopped there. The result is a gap shaped exactly like the questions people bring to this page, about men, about months of use and about diets, and the gap is the honest answer rather than a sign that nothing goes wrong.

HCG side effects and safety data